Munich, 20 December 2016. Blättchen & Partner has supported the management team of BSN medical (“BSN”) in the sale by EQT VI Limited to Svenska Cellulosa Aktiebolaget (“SCA”). The transaction values BSN at EUR 2.74 billion.
BSN medical is a leading global medical device company in the fields of wound care, vascular disease, lymphology and non-invasive orthopedics. The company was founded in 2001 and currently employs 6000 people and generated sales of EUR 861 million in 2015.
Blättchen & Partner advised BSN Management in the context of the transaction with Prof. Dr. Alexander Götz.